Stockscreener 앱 받기
114.20
0.26%
-0.30
시간 외 거래:
114.30
0.10
+0.09%
전일 마감가:
$114.50
열려 있는:
$114.66
하루 거래량:
8.35M
Relative Volume:
0.67
시가총액:
$282.35B
수익:
$64.93B
순이익/손실:
$18.26B
주가수익비율:
15.70
EPS:
7.2751
순현금흐름:
$12.36B
1주 성능:
-1.48%
1개월 성능:
-6.29%
6개월 성능:
+40.11%
1년 성능:
+21.46%
1일 변동 폭
$113.75
$115.76
1주일 범위
$113.34
$117.89
52주 변동 폭
$73.31
$125.14
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
114.20 | 283.09B | 64.93B | 18.26B | 12.36B | 7.2751 |
|
LLY
Lilly Eli Co
|
917.50 | 819.81B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
237.60 | 571.52B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
206.23 | 368.38B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
188.93 | 292.21B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
148.19 | 285.86B | 54.72B | 14.02B | 15.32B | 7.1855 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2026-02-20 | 개시 | Barclays | Overweight |
| 2026-02-13 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-10-13 | 재개 | Citigroup | Neutral |
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Pfizer vs Moderna: Which Pharma Stock Has More Upside? - The Motley Fool
The Zacks Analyst Blog Highlights Merck, TotalEnergies and Union Pacific - The Globe and Mail
Zacks Research Upgrades Merck & Co., Inc. (NYSE:MRK) to "Hold" - MarketBeat
Merck & Co., Inc.: A new test of the support level - marketscreener.com
Jefferies Adjusts Price Target on Merck & Co. to $132 From $130, Maintains Buy Rating - marketscreener.com
Groupama Asset Managment Buys 49,541 Shares of Merck & Co., Inc. $MRK - MarketBeat
11,009 Shares in Merck & Co., Inc. $MRK Purchased by Lantern Wealth Advisors LLC - MarketBeat
CIBC Bancorp USA Inc. Acquires New Shares in Merck & Co., Inc. $MRK - MarketBeat
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck An - pharmiweb.com
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs - Business Wire
MERCK & CO., INC. (MRK) - MSN
Is Merck & Co., Inc. (MRK) a good stock to buy now? - MSN
Top Analyst Reports for Merck, TotalEnergies & Union Pacific - Zacks Investment Research
Danske Bank A S Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Caerus Investment Advisors LLC Makes New $1.31 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Coldstream Capital Management Inc. - MarketBeat
Campbell Capital Management Inc. Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Danica Pension Livsforsikringsaktieselskab Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Captrust Financial Advisors Has $103.94 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Mariner LLC - MarketBeat
Moors & Cabot Inc. Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
National Bank of Canada FI Sells 1,834,181 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Mercer Global Advisors Inc. ADV - MarketBeat
L2 Asset Management LLC Purchases 8,812 Shares of Merck & Co., Inc. $MRK - MarketBeat
646,011 Shares in Merck & Co., Inc. $MRK Bought by Holocene Advisors LP - MarketBeat
Destination Wealth Management Cuts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
CSM Advisors LLC Has $1.91 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Ausdal Financial Partners Inc. Purchases 9,731 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck completes purchase of biopharma company making experimental flu drug - WFMZ.com
Wells Fargo Raises Merck (MRK) Target on Sac-TMT Potential - Insider Monkey
MRK Stock Quote Price and Forecast - CNN
Merck & Co., Inc. (MRK) Advances Oncology Pipeline with Breakthrough FDA Designation for Ovarian Cancer Drug - MSN
Merck & Co. Inc. (NYSE:MRK) Offers a Steady Dividend Backed by Strong Fundamentals - ChartMill
Here’s Why Merck (MRK) Surged in Q4 - Insider Monkey
Merck & Co., Inc. $MRK Shares Purchased by Hamilton Wealth LLC - MarketBeat
Gotham Asset Management LLC Acquires 113,226 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fayez Sarofim & Co Has $201.96 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Wealth Buys 22,132 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Merck & Co., Inc. Stock (ISIN: US58933Y1055) Hits Dividend Date as Analysts Raise Targets on Oncolog - AD HOC NEWS
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now? - Insider Monkey
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss - Insider Monkey
Crawford Investment Counsel Inc. Reduces Merck & Co. Holdings - National Today
Elevation Point Wealth Partners LLC Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Crawford Investment Counsel Inc. Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Brevan Howard Capital Management LP Sells 355,802 Shares of Merck & Co., Inc. $MRK - MarketBeat
Circle Wealth Management LLC Has $13.62 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Cinctive Capital Management LP Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by California Public Employees Retirement System - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.27%
자본화:
|
볼륨(24시간):